| Targeting strategies for tissue-specific drug delivery Z Zhao, A Ukidve, J Kim, S Mitragotri Cell 181 (1), 151-167, 2020 | 616 | 2020 |
| Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers Z Zhao, A Ukidve, V Krishnan, S Mitragotri Advanced drug delivery reviews 143, 3-21, 2019 | 327 | 2019 |
| Cellular backpacks for macrophage immunotherapy CW Shields IV, MA Evans, LLW Wang, N Baugh, S Iyer, D Wu, Z Zhao, ... Science Advances 6 (18), eaaz6579, 2020 | 268 | 2020 |
| Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis Z Zhao, A Ukidve, Y Gao, J Kim, S Mitragotri Science Advances 5 (11), eaax9250, 2019 | 124 | 2019 |
| A polymer-based systemic hemostatic agent Y Gao, A Sarode, N Kokoroskos, A Ukidve, Z Zhao, S Guo, R Flaumenhaft, ... Science advances 6 (31), eaba0588, 2020 | 91 | 2020 |
| Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function A Ukidve, Z Zhao, A Fehnel, V Krishnan, DC Pan, Y Gao, A Mandal, ... Proceedings of the National Academy of Sciences 117 (30), 17727-17736, 2020 | 83 | 2020 |
| Transdermal immunomodulation: Principles, advances and perspectives Z Zhao, A Ukidve, A Dasgupta, S Mitragotri Advanced Drug Delivery Reviews 127, 3-19, 2018 | 82 | 2018 |
| Vascular drug delivery using carrier red blood cells: focus on RBC surface loading and pharmacokinetics PM Glassman, CH Villa, A Ukidve, Z Zhao, P Smith, S Mitragotri, ... Pharmaceutics 12 (5), 440, 2020 | 76 | 2020 |
| Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases Z Zhao, A Ukidve, V Krishnan, A Fehnel, DC Pan, Y Gao, J Kim, MA Evans, ... Nature Biomedical Engineering 5 (5), 441-454, 2021 | 66 | 2021 |
| Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations A Mandal, N Kumbhojkar, C Reilly, V Dharamdasani, A Ukidve, DE Ingber, ... Science advances 6 (30), eabb6049, 2020 | 59 | 2020 |
| Macrophage‐Mediated Delivery of Hypoxia‐Activated Prodrug Nanoparticles MA Evans, CW Shields IV, V Krishnan, LLW Wang, Z Zhao, A Ukidve, ... Advanced Therapeutics 3 (2), 1900162, 2020 | 28 | 2020 |
| Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer D Wu, Z Zhao, J Kim, A Razmi, LLW Wang, N Kapate, Y Gao, K Peng, ... Bioengineering & translational medicine 6 (1), e10188, 2021 | 22 | 2021 |
| Ionic‐Liquid‐Based Safe Adjuvants A Ukidve, K Cu, M Goetz, P Angsantikul, A Curreri, EEL Tanner, J Lahann, ... Advanced Materials 32 (46), 2002990, 2020 | 21 | 2020 |
| Injectable hyaluronic acid hydrogels encapsulating drug nanocrystals for long‐term treatment of inflammatory arthritis Y Gao, D Vogus, Z Zhao, W He, V Krishnan, J Kim, Y Shi, A Sarode, ... Bioengineering & Translational Medicine 7 (1), e10245, 2022 | 18 | 2022 |
| Overcoming biological barriers to improve solid tumor immunotherapy A Ukidve, K Cu, N Kumbhojkar, J Lahann, S Mitragotri Drug Delivery and Translational Research, 1-26, 2021 | 14 | 2021 |
| Succinate Buffer in Biologics Products: Real-world Formulation Considerations, Processing Risks and Mitigation Strategies A Ukidve, KB Rembert, R Vanipenta, P Dorion, P Lafarguette, T McCoy, ... Journal of Pharmaceutical Sciences 112 (1), 138-147, 2023 | 5 | 2023 |
| Methods and compositions relating to ionic liquid adjuvants S Mitragotri, AA Ukidve, CU Katharina US Patent App. 17/921,158, 2023 | 1 | 2023 |
| Anti-complement c1s antibody formulation S Patke, AA Ukidve US Patent App. 18/334,567, 2024 | | 2024 |
| Compositions and methods relating to erythrocytes with adhered particles S Mitragotri, AA Ukidve, Z Zongmin | | 2020 |
| Erythrocyte Anchored Systemic Immunotherapy: Metastasis Driven Cancer Immunotherapy for Local and Systemic Tumor Suppression Z Zhao, A Ukidve, S Mitragotri 2020 Virtual AIChE Annual Meeting, 2020 | | 2020 |
Samir MitragotriHarvard University, Wyss Institute, UC Santa Barbara, MIT在 g.harvard.edu 的电子邮件经过验证
